Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence
about
The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung diseaseSequence and molecular characterization of human monocyte/neutrophil elastase inhibitorPrenyl group identification of rap2 proteins: a ras superfamily member other than ras that is farnesylatedThe trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide coreA locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic proteinConstitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epitheliaElafin is a biomarker of graft-versus-host disease of the skinThe evolution of a genetic locus encoding small serine proteinase inhibitorsInnate immune defences in the human endometriumThe Role of Serine Proteases and Antiproteases in the Cystic Fibrosis LungComplex of human neutrophil elastase with 1/2SLPIEndocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptorsEvolution of trappin genes in mammalsA double WAP domain-containing protein Es-DWD1 from Eriocheir sinensis exhibits antimicrobial and proteinase inhibitory activitiesIdentification of novel functional sequence variants in the gene for peptidase inhibitor 3.Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids.Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.Antimicrobial activity of murine lung cells against Staphylococcus aureus is increased in vitro and in vivo after elafin gene transfer.Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditisTumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight formsThe neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer.Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:CEngineering kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variantHE4 as a biomarker for ovarian and endometrial cancer management.De Novo sequencing and transcriptome analysis for Tetramorium bicarinatum: a comprehensive venom gland transcriptome analysis from an ant species.Neutrophil elastase inhibitors.Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancerfTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms.Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesionsThe serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase.A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammation.Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates.Post-cardiac transplant arteriopathy in piglets is associated with fragmentation of elastin and increased activity of a serine elastase.Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases.IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of the oesophagus
P2860
Q21146748-D7908019-A921-46B6-AAF6-E3FFE897F31FQ24292832-535C2CA7-D778-45D4-AB08-39C33001C456Q24527573-A3D34598-FE62-4CEC-A60F-01E13B242E11Q24531515-177AE8AD-7CFE-4A2B-A966-B241299B8EFAQ24534896-AED37D61-5D7F-4A35-AE17-D085B0A25B37Q24561981-B531A905-BE92-4E9E-9C48-A52F005D3FC0Q24622918-5E0C82EB-E2D4-49A9-A796-56B929915B41Q24682006-C310D76A-02D3-4150-8C16-DEAC9B662440Q24801159-1E098B64-CF91-4079-A7BD-F1E108B242E0Q26799771-DFCEFDEB-56A5-40C3-99F3-D68AFA643C11Q27650385-41D6A6DB-E745-4C29-BB8B-9D13C4AC9E11Q28388054-CB99B056-F521-48F2-8D3A-C0D28836DB62Q28748658-1678A8D3-750B-4AC2-86E0-A2B8A78BE223Q30393290-23DC6B9A-E41C-49AE-9289-FF9F3C8AA3E4Q30816447-C4E7D3E8-01D8-45DB-93DA-85AC522CA221Q33418209-F7A3FEC9-4C6C-4272-AA9A-30F45370C357Q33622587-0CCF20DF-94C0-46AF-96F9-3791066D6B90Q33713275-4B2FD6E9-A813-40D2-A737-EF23EE1C21EDQ33788207-48F027C1-C7AC-4753-8806-E74E6D26EBE8Q33849246-05166275-5840-49DF-A9BC-E8221F544B9CQ33969505-8F79354A-8144-45FD-84EC-49E2660C8F45Q34134278-C1EF73A0-0E7F-4EFB-A73A-5AD4856418F4Q34149948-02A4D1A3-B5C5-4181-BB44-44A6F5C221B6Q34251265-65359C67-48E6-4E39-9F4C-070CD9187859Q34575895-739DCC7D-AF5E-4F84-A6DA-9CB89EACDF7EQ34611530-57F79E1C-04E9-47D7-991C-F486BBBB8EB1Q34636565-1691CC5B-A63E-42FD-95C5-BC9546662B5AQ34814104-915AD67D-741F-46B4-AC75-654A86BB8DA8Q35017292-060DEE5C-606A-4798-AEC5-D668CBA6963BQ35021181-11D8094A-40CA-4FA8-AC1F-FB70B360EE0EQ35079179-0988A185-09D2-4671-B2EE-C2963EA1865AQ35166076-DC4E5348-E19F-480A-B15B-92306DA251CFQ35168267-650ED7C3-E9A2-405D-AFA7-638ABDF04E50Q35185357-5E076213-747B-419A-9A79-A0996D9CFECDQ35591399-5D7EB9F6-93E6-4E17-90F9-43B58797DA08Q35661217-BB47C9F0-D088-4B4A-806D-A01ED5F5C942Q35833724-DDFEDF94-2B2B-4459-B46C-604C75649324Q36093198-005F3373-0BFE-4A8E-A985-D04DE8775809Q36288515-7AB44EAA-9BAE-48D5-B45B-227321CBFA0EQ36431252-16897D84-4C33-441A-9924-2FAE4B0165CC
P2860
Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Elafin: an elastase-specific i ...... d complete amino acid sequence
@ast
Elafin: an elastase-specific i ...... d complete amino acid sequence
@en
Elafin: an elastase-specific i ...... d complete amino acid sequence
@en-gb
Elafin: an elastase-specific i ...... d complete amino acid sequence
@nl
type
label
Elafin: an elastase-specific i ...... d complete amino acid sequence
@ast
Elafin: an elastase-specific i ...... d complete amino acid sequence
@en
Elafin: an elastase-specific i ...... d complete amino acid sequence
@en-gb
Elafin: an elastase-specific i ...... d complete amino acid sequence
@nl
prefLabel
Elafin: an elastase-specific i ...... d complete amino acid sequence
@ast
Elafin: an elastase-specific i ...... d complete amino acid sequence
@en
Elafin: an elastase-specific i ...... d complete amino acid sequence
@en-gb
Elafin: an elastase-specific i ...... d complete amino acid sequence
@nl
P2093
P3181
P1476
Elafin: an elastase-specific i ...... d complete amino acid sequence
@en
P2093
E Christophers
J M Schröder
P304
P3181
P407
P577
1990-09-05T00:00:00Z